The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke: Results of a Prematurely Terminated Randomized Clinical Trial
Open accessAbstract
Background and Purpose— Intravenous alteplase (rtPA) remains the only approved treatment for acute ischemic stroke, but its use remains limited. In a previous pilot dose-escalation study, intravenous tenecteplase showed promise as a potentially safer alternative. Therefore, a Phase IIB clinical trial was begun to (1) choose a best dose of tenecteplase to carry forward; and (2) to provide evidence for either promise or futility of further testing of tenecteplase versus rtPA. If promise was established, then the trial would continue as a Phase III efficacy trial comparing the selected tenecteplase dose to standard rtPA. Methods— The trial began as a small, multicenter, randomized, double-blind, controlled clinical trial comparing 0.1, 0.25, and 0.4 mg/kg tenecteplase with standard 0.9 mg/kg rtPA in patients with acute stroke within 3 hours of onset. An adaptive sequential design used an early (24-hour) assessment of major neurological improvement balanced against occurrence of symptomatic intracranial hemorrhage to choose a “best” dose of tenecteplase to carry forward. Once a “best” dose was established, the trial was to continue until at least 100 pairs of the selected tenecteplase dose versus standard rtPA could be compared by 3-month outcome using the modified Rankin Scale in an interim analysis. Decision rules were devised to yield a clear recommendation to either stop for futility or to continue into Phase III. Results— The trial was prematurely terminated for slow enrollment after only 112 patients had been randomized at 8 clinical centers between 2006 and 2008. The 0.4-mg/kg dose was discarded as inferior after only 73 patients were randomized, but the selection procedure was still unable to distinguish between 0.1 mg/kg and 0.25 mg/kg as a propitious dose at the time the trial was stopped. There were no statistically persuasive differences in 3-month outcomes between the remaining tenecteplase groups and rtPA. Symptomatic intracranial hemorrhage rates were highest in the discarded 0.4-mg/kg tenecteplase group and lowest (0 of 31) in the 0.1-mg/kg tenecteplase group. Neither promise nor futility could be established. Conclusion— This prematurely terminated trial has demonstrated the potential efficiency of a novel design in selecting a propitious dose for future study of a new thrombolytic agent for acute stroke. Given the truncation of the trial, no convincing conclusions can be made about the promise of future study of tenecteplase in acute stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Self-citationVan de Werf, F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07403-6 · Cited by 885
van der Worp, H. B., & van Gijn, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp072057 · Cited by 399
A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
Haley, E. C., Lyden, P. D., Johnston, K. C., Hemmen, T. M., & the TNK in Stroke Investigators (2005) · Stroke · doi:10.1161/01.str.0000154872.73240.e9 · Cited by 222
Self-citationBrown, D. L., Barsan, W. G., Lisabeth, L. D., Gallery, M. E., & Morgenstern, L. B. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.12.025 · Cited by 170
Self-citationBrown, D. L., Johnston, K. C., Wagner, D. P., & Haley, E. C. (2004) · Stroke · doi:10.1161/01.str.0000105396.93273.72 · Cited by 159
Self-citationNIHSS Training and Certification Using a New Digital Video Disk Is Reliable
Lyden, P. D., Raman, R., Liu, L., Grotta, J. C., Broderick, J. P., Olson, S. J., Shaw, S., Spilker, J. A., Meyer, B. C., Emr, M., et al. (2005) · Stroke · doi:10.1161/01.str.0000185725.42768.92 · Cited by 135
Self-citationParsons, M. W., Miteff, F., Bateman, G. A., Spratt, N. J., Loiselle, A., Attia, J., & Levi, C. R. (2009) · Neurology · doi:10.1212/01.wnl.0000344168.05315.9d · Cited by 116
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., Yan, B., Bush, S. J., Dewey, H. M., Thijs, V., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716405 · Cited by 885
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
Parsons, M., Spratt, N., Bivard, A., Campbell, B., Chung, K., Miteff, F., O'Brien, B., Bladin, C., McElduff, P., Allen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109842 · Cited by 680
Metadata
- Authors
- Haley, E. C., Thompson, J. L. P., Grotta, J. C., Lyden, P. D., Hemmen, T. G., Brown, D. L., Fanale, C., Libman, R., Kwiatkowski, T. G., Llinas, R. H., Levine, S. R., Johnston, K. C., Buchsbaum;, R., Levy, G., & Levin, B.
- Venue
- Stroke
- Published
- 2010-04
- Volume
- 41
- Issue
- 4
- Pages
- 707-711
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1900208830
- Cited by
- 271
- References
- 10
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.